GuideAI Health Corp.
NNEO:GDAI1.00
CAD
0.00
(0.00%)
ISIN
CA40173G1019
CUSIP
40173G101
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Semi-annual Revenue
USD
•
in mil. unless spec.Semi-annual Earnings Per Share
USD
•
in mil. unless spec.Semi-annual Dividends Per Share
USD
•
in mil. unless spec.Company Description
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Vancouver Canada
- Website
- guideaihealth.com
- Similar Companies
- Business
- GuideAI Health Corp. is a digital healthcare and medical artificial intelligence technology company that develops, commercializes, and operates AI-driven clinical decision support systems, diagnostic workflow automation tools, and predictive health analytics platforms. The company provides a comprehensive suite of proprietary software solutions designed to optimize clinical operations, reduce administrative burden for practitioners, and enhance patient outcomes across hospital networks, outpatient clinics, and telemedicine providers. Its core products and services include GuideAI Clinical Copilot, an artificial intelligence-powered ambient clinical documentation and automated transcription tool; GuideAI Triage, an automated symptom assessment and patient risk stratification engine; GuideAI Diagnostics, a machine learning-based decision-support platform for medical imaging analysis and clinical data interpretation; GuideAI RemoteCare, a continuous remote patient monitoring and predictive early-warning system for chronic disease management; and GuideAI Core Platform, an enterprise-grade, cloud-based data integration and electronic health record interoperability hub. The company operates through two main business segments: Enterprise Healthcare Solutions and Clinical AI Software, providing its technologies primarily via Software-as-a-Service (SaaS) and enterprise licensing models. GuideAI Health Corp. serves healthcare systems, academic medical centers, independent physician associations, and digital health organizations across North America, with primary commercial operations in Canada and the United States. Founded in 2021 and headquartered in Toronto, Ontario, Canada, the company operates regional sales, research, and support hubs across the region. In recent developments, GuideAI Health Corp. completed a corporate reorganization and qualifying transaction to list its common shares on Cboe Canada (formerly the NEO Exchange) under the ticker symbol GDAI; entered into a multi-year strategic commercial partnership with regional hospital networks to deploy its ambient clinical AI tools across acute care environments; completed the strategic acquisition of a specialized clinical data analytics firm to enhance its diagnostic predictive modeling capabilities; and launched its next-generation multimodal generative AI clinical documentation platform with direct integration into major electronic medical record ecosystems.